Hindustan Times•National•19 ఆగ
Moderna Stock Jumps 120 After Cancer Vaccine Trial Win What Investors Need To Know
Moderna s stock is soaring after major cancer vaccine news. Moderna and Merck said on Wednesday that their experimental personalized cancer vaccine showed positive results in its first-ever Phase 3 trial